Stock Watch: Roche’s Long Shot Over Its Patent Cliff

Is Big Pharma Losing Its Defensive Investment Attributes?

 
• By Andy Smith
  
Andy Smith
ANDY SMITH OFFERS A LIFE SCIENCE INVESTOR'S PERSPECTIVE ON BIOPHARMA BUSINESS

More from Stock Watch

More from Business